Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells 5,936 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) insider Nicholas Hollmeyer Lynton sold 5,936 shares of the company’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $3.08, for a total value of $18,282.88. Following the completion of the transaction, the insider now owns 85,445 shares of the company’s stock, valued at $263,170.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Cardlytics Stock Up 7.5 %

Shares of Cardlytics stock opened at $3.29 on Friday. Cardlytics, Inc. has a twelve month low of $2.89 and a twelve month high of $20.52. The stock has a market cap of $160.50 million, a price-to-earnings ratio of -0.74 and a beta of 1.67. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01. The company has a fifty day moving average price of $4.35 and a 200 day moving average price of $8.52.

Cardlytics (NASDAQ:CDLXGet Free Report) last issued its earnings results on Wednesday, August 7th. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.12. The company had revenue of $69.64 million during the quarter, compared to the consensus estimate of $75.39 million. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The company’s revenue was down 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.57) earnings per share. Equities research analysts forecast that Cardlytics, Inc. will post -1.72 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Canton Hathaway LLC increased its position in shares of Cardlytics by 95.7% during the second quarter. Canton Hathaway LLC now owns 4,500 shares of the company’s stock worth $37,000 after acquiring an additional 2,200 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Cardlytics during the 3rd quarter valued at approximately $45,000. XTX Topco Ltd purchased a new stake in Cardlytics during the 2nd quarter worth approximately $107,000. Quest Partners LLC raised its position in shares of Cardlytics by 160.4% in the 2nd quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock valued at $147,000 after purchasing an additional 11,061 shares in the last quarter. Finally, Clear Street Markets LLC purchased a new position in shares of Cardlytics during the 4th quarter valued at approximately $199,000. 68.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CDLX has been the subject of a number of research analyst reports. Needham & Company LLC downgraded shares of Cardlytics from a “buy” rating to a “hold” rating in a research note on Thursday, August 8th. Bank of America downgraded shares of Cardlytics from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $4.00 to $3.50 in a report on Thursday, August 15th. Northland Capmk downgraded shares of Cardlytics from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 16th. Craig Hallum cut shares of Cardlytics from a “buy” rating to a “hold” rating in a research note on Thursday, August 8th. Finally, Northland Securities lowered Cardlytics from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $7.00 to $5.00 in a research report on Friday, August 16th. One analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $7.50.

Read Our Latest Stock Report on Cardlytics

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

See Also

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.